Complement and autoimmunity (Q45169996)

10 December 2017

Complement and autoimmunity (English)

1 reference

10 December 2017

6

1 reference

10 December 2017

Carlo Perricone

2

0 references

author name string

Eleonora Ballanti

1

1 reference

10 December 2017

Elisabetta Greco

3

1 reference

10 December 2017

Marta Ballanti

4

1 reference

10 December 2017

Gioia Di Muzio

5

1 reference

10 December 2017

Roberto Perricone

7

1 reference

10 December 2017

language of work or name

1 reference

1 July 2013

1 reference

10 December 2017

1 reference

10 December 2017

56

1 reference

10 December 2017

2-3

1 reference

10 December 2017

477-491

1 reference

https://scigraph.springernature.com/pub.10.1007/s12026-013-8422-y

10 December 2017

0 references

cites work

Complement resistance in microbes

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement: central to innate immunity and bridging to adaptive responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement and Toll-like receptors: key regulators of adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Early complement proteases: C1r, C1s and MASPs. A structural insight into activation and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

The Role of the Complement System in Innate Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Control of the complement system.

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

21 January 2018

12 December 2020

Human complement regulators: a major target for pathogenic microorganisms

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

The pathophysiology of hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

A regulatory role for complement in innate immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement activity and pharmacological inhibition in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement and its breakdown products in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Noninvasive detection of complement activation through radiologic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

The complement system in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Clinical significance of complement deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Immune deficiency and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Autoimmune manifestations in primary immune deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

The clearance of apoptotic cells: implications for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

The classical and regulatory functions of C1q in immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement deficiencies and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Updating on the pathogenesis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

The role of complement in the development of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Systemic lupus erythematosus, complement deficiency, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

The localization of in vivo bound complement in tissue section

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Autoimmunity to type II collagen an experimental model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Induction of arthritis in monkeys by immunization with type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

A review of current knowledge of the complement system and the therapeutic opportunities in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement factor 2 deficiency: a clinical and serological family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Synthesis of complement components by synovial membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement activating properties of monoreactive and polyreactive IgM rheumatoid factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement fixation by rheumatoid factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Activation of the complement and properdin systems in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement activation by C-reactive protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Structure, function and cellular expression of complement anaphylatoxin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

A critical role for murine complement regulator crry in fetomaternal tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Pathogenesis and therapies of immune-mediated myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Pathogenesis of Takayasu's arteritis: a 2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

The antineutrophil cytoplasmic antibody-associated vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Pathophysiology of ANCA-associated small vessel vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Mesangial C4d deposition: a new prognostic factor in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

The complement system as a therapeutic target in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Therapeutic inhibition of the complement system. Y2K update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Generation of a recombinant, membrane-targeted form of the complement regulator CD59: activity in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Replacement therapy with C1 esterase inhibitors for hereditary angioedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Complement therapeutics; history and current progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Immunisation against heterologous type II collagen induces arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8422-Y

Alternative pathway complement activation in rheumatoid arthritis

21 January 2018

1 reference

12 December 2020

Therapeutic inhibition of the complement system.

1 reference

12 December 2020

CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats

1 reference

12 December 2020

Complement activation in patients with primary antiphospholipid syndrome

1 reference

12 December 2020

Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products

1 reference

12 December 2020

Local production of complement proteins in rheumatoid arthritis synovium

1 reference

12 December 2020

Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus

1 reference

12 December 2020

Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B

1 reference

12 December 2020

Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues

1 reference

12 December 2020

Complement protein C1q induces maturation of human dendritic cells

1 reference

12 December 2020

Complement activation by 19S IgM rheumatoid factor: relationship to disease activity in rheumatoid arthritis

1 reference

12 December 2020

Complement biosynthesis in human synovial tissue

1 reference

12 December 2020

Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses

1 reference

12 December 2020

Deposition of membrane attack complex in cutaneous lesions of lupus erythematosus

1 reference

12 December 2020

Decrease in detectable complement receptor type 1 levels on erythrocytes from patients with psoriatic polyarthritis

1 reference

12 December 2020

Complement activation in patients with sepsis is in part mediated by C-reactive protein

1 reference

12 December 2020

Microvascular deposition of complement membrane attack complex in dermatomyositis

1 reference

12 December 2020

Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

Activation of the complement system in systemic sclerosis. Relationship to clinical severity

1 reference

12 December 2020

A novel ELISA assay for the detection of C3 nephritic factor

1 reference

12 December 2020

Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis

1 reference

12 December 2020

Topics in clinical medicine. Complement levels in disease

1 reference

12 December 2020

Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation

1 reference

12 December 2020

Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)

1 reference

12 December 2020

Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis

1 reference

12 December 2020

Complement C3 cleavage product in synovial fluids detected by immunofixation.

1 reference

12 December 2020

Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen.

1 reference

12 December 2020

Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin

1 reference

12 December 2020

Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease

1 reference

12 December 2020

Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment

1 reference

12 December 2020

Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice

1 reference

12 December 2020

High-dose intravenous immunoglobulin treatment activates complement in vivo

1 reference

12 December 2020

Membrane Attack Complex Deposits in Cutaneous Lesions of Dermatomyositis

1 reference

12 December 2020

Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia

1 reference

12 December 2020

C3 Activation Products, C3 Containing Immune Complexes, the Terminal Complement Complex and Native C9 in Patients with Rheumatoid Arthritis

1 reference

12 December 2020

Complement activation in psoriasis

1 reference

12 December 2020

Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis

1 reference

12 December 2020

Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways

1 reference

12 December 2020

C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction

1 reference

12 December 2020

Intra-articular and circulating immune complexes and antiglobulins (IgG and IgM) in rheumatoid arthritis; correlation with clinical features

1 reference

12 December 2020

Serum complement pattern in essential mixed cryoglobulinaemia

1 reference

12 December 2020

Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid

1 reference

12 December 2020

Discrimination of hepatocyte-stimulating activity from human recombinant tumor necrosis factor alpha

1 reference

12 December 2020

Regulation of hepatic synthesis of C3 and C4 during the acute-phase response in the rat

1 reference

12 December 2020

Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment.

1 reference

12 December 2020

Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex

1 reference

12 December 2020

Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein

1 reference

12 December 2020

Quantitation of components of the alternative pathway of complement (APC) by enzyme-linked immunosorbent assays

1 reference

12 December 2020

Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias.

1 reference

12 December 2020

Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium

1 reference

12 December 2020

Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells

1 reference

12 December 2020

Synthesis and regulation of the two human complement C4 genes in stable transfected mouse fibroblasts

1 reference

12 December 2020

Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus

1 reference

12 December 2020

CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes

1 reference

12 December 2020

Complement Deficiency Ameliorates Collagen-Induced Arthritis in Mice

1 reference

12 December 2020

The role of complement in B cell activation and tolerance.

1 reference

12 December 2020

Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein

1 reference

12 December 2020

Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation

1 reference

12 December 2020

10.1007/S12026-013-8422-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

0 references

1 reference